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Abstract. A regiocontrolled total synthesis of cervinomycin A1 and A2 has been achieved 
utilizing simple and easily accessible reagents under viable reaction conditions. An approach 
towards the synthesis of the taxol skeleton using intramolecular Diels-Alder reaction followed 
by Wittig rearrangement is described. 
Cancer, a complex of diseases associated with the abnormal growth of new body tissues, is a most 
dreadhl disease in the world today. About 20% of the deaths in western countries occur due to neoplastic 
diseases and today, it is one of the third largest killer diseases in India. The most alarming aspects of cancer 
in India is that it affects the Indian 15-20 years earlier than their counterpart in western countries. This could 
be due to the climatic conditions. Radiation and surgery are the effective tools to combat it as long as this 
disease is detected early and localized. However, by the time it is detected it often spreads to other parts of 
the body. Chemotherapy or its combination with the radiation is the only solution. Realising the need and 
problem, we initiated a programme to develop chemotherapeutic agents. The synthesis of Cervinomycin 1 & 
- 2 and Tax01 4 will be discussed. 
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Cervinomycin, produced by Streptomyces cervznus sp. nov., is an antibiotic possessing (ref. 1) strong 
inhibitory activity against anaerobic bacteria and mycoplasma Cervinomycin consists of two components 
A1 1 and A2 2 which are insoluble in most of the organic solvents. However, triacetyl cervinomycin 3 has 
high solubility and is developed as a drug because of its low toxicity and enhanced activity. Cervinomycin's 
unique structure, which possesses a sensitive isoquinolone moiety hsed angularly with a novel and highly 
finctionalized xanthone unit makes it a synthetically challenging target. A programme was therefore 
initiated on its total synthesis (ref. 2,3) with the aim to prepare chemical variants of 1 to hrther examine 
therapeutic efficacy. 
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